Abstract
Relapsed rhabdomyosarcoma (RMS) represents a significant therapeutic challenge. Nearly one-third of patients diagnosed with localized RMS and over two......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
